Kiniksa Pharmaceuticals International (KNSA) Inventory Average (2021 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Inventory Average came in at $72.0 million in Q2 2026, up 105.08% YoY from $35.1 million in Q2 2025, and up 12.52% on a QoQ basis from $64.0 million in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) Inventory Average (2021 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 6 years of Inventory Average data on file, last reported at $72.0 million in Q2 2026.
- Quarterly Inventory Average rose 105.08% year-over-year to $72.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $72.0 million (up 105.08% YoY) and the FY2025 annual result came in at $40.6 million, up 41.35% from the prior year.
- Inventory Average advanced to $72.0 million in Q2 2026, from $64.0 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $72.0 million in Q2 2026 to a low of $8.4 million in Q1 2022.
- A 5-year average of $31.5 million and a median of $27.9 million in 2023 frame the typical range for Inventory Average.
- Annual changes were most pronounced in 2022 — Inventory Average surged 290.26% — and 2025, when it fell 17.07%.
- Tracing KNSA's Inventory Average over 5 years: stood at $18.1 million in 2022, then jumped by 56.56% to $28.4 million in 2023, then dropped by 2.93% to $27.5 million in 2024, then soared by 74.93% to $48.1 million in 2025, then soared by 49.62% to $72.0 million in 2026.
- The last three Inventory Average figures came in at $72.0 million (Q2 2026), $64.0 million (Q1 2026), and $48.1 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 824.00 Mn |
| 10 | Kiniksa Pharmaceuticals International | 6.07 Bn | 5.54 Bn | 220.03 Mn | 72.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 72.04 Mn |
| Mar 31, 2026 | 64.02 Mn |
| Dec 31, 2025 | 48.15 Mn |
| Sep 30, 2025 | 44.79 Mn |
| Jun 30, 2025 | 35.13 Mn |
| Mar 31, 2025 | 24.22 Mn |
| Dec 31, 2024 | 27.52 Mn |
| Sep 30, 2024 | 31.77 Mn |
| Jun 30, 2024 | 31.07 Mn |
| Mar 31, 2024 | 29.20 Mn |
| Dec 31, 2023 | 28.35 Mn |
| Sep 30, 2023 | 24.77 Mn |
| Jun 30, 2023 | 23.69 Mn |
| Mar 31, 2023 | 22.51 Mn |
| Dec 31, 2022 | 18.11 Mn |
| Sep 30, 2022 | 17.27 Mn |
| Jun 30, 2022 | 16.57 Mn |
| Mar 31, 2022 | 8.45 Mn |
| Dec 31, 2021 | 4.64 Mn |
| Sep 30, 2021 | 5.99 Mn |